Comments
Loading...

Revolution Medicines

RVMDNASDAQ
Logo brought to you by Benzinga Data
$44.74
0.681.54%
Last update: 9:40 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$71.00
Lowest Price Target1
$23.00
Consensus Price Target1
$48.28

Revolution Medicines (NASDAQ:RVMD) Stock, Analyst Ratings, Price Targets, Forecasts

Revolution Medicines Inc has a consensus price target of $48.28 based on the ratings of 18 analysts. The high is $71 issued by Morgan Stanley on March 8, 2024. The low is $23 issued by Goldman Sachs on March 1, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., JP Morgan, and Wedbush on August 12, 2024, August 8, 2024, and August 8, 2024, respectively. With an average price target of $56.33 between HC Wainwright & Co., JP Morgan, and Wedbush, there's an implied 25.91% upside for Revolution Medicines Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Apr
1
May
3
Jul
2
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
JP Morgan
Wedbush
Needham
Barclays

1calculated from analyst ratings

Analyst Ratings for Revolution Medicines

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Revolution Medicines (RVMD) stock?

A

The latest price target for Revolution Medicines (NASDAQ:RVMD) was reported by HC Wainwright & Co. on August 12, 2024. The analyst firm set a price target for $56.00 expecting RVMD to rise to within 12 months (a possible 25.17% upside). 34 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Revolution Medicines (RVMD)?

A

The latest analyst rating for Revolution Medicines (NASDAQ:RVMD) was provided by HC Wainwright & Co., and Revolution Medicines reiterated their buy rating.

Q

When was the last upgrade for Revolution Medicines (RVMD)?

A

The last upgrade for Revolution Medicines Inc happened on April 10, 2024 when Raymond James raised their price target to $48. Raymond James previously had an outperform for Revolution Medicines Inc.

Q

When was the last downgrade for Revolution Medicines (RVMD)?

A

There is no last downgrade for Revolution Medicines.

Q

When is the next analyst rating going to be posted or updated for Revolution Medicines (RVMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Revolution Medicines, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Revolution Medicines was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

Q

Is the Analyst Rating Revolution Medicines (RVMD) correct?

A

While ratings are subjective and will change, the latest Revolution Medicines (RVMD) rating was a reiterated with a price target of $56.00 to $56.00. The current price Revolution Medicines (RVMD) is trading at is $44.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch